Op2Lysis SAS announced the signature of a license agreement with CARLINA Technologies for exploiting its PEPTIDOTSTM technology.
Read the press release below for more information
————————- Our team ————————-
“Our ambition is to become a leader in research and development for stroke.”
117, avenue Victor Hugo, 92100 Boulogne-Billancourt